AlloCure's Series B Round

AlloCure raised a round of funding on April 02, 2012.

AlloCure is a biotechnology company developing the use of cell therapy for the treatment of kidney disease. AlloCure's technology allows for the isolation and expansion of a specific population of mes…

Articles about AlloCure's Series B Round: